MT. Spokane Pediatrics, PLLC

MT. Spokane Pediatrics, PLLC was paid $12.37M by Medicaid between Jan 2018 and Nov 2024, across 91 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 32% of everything it billed.

33Billing provider infoMT. SPOKANE PEDIATRICS, PLLC
SPOKANE, WA 99218

33aNPI1477934578assigned 06/15/2015

33bProvider typeCustomized Equipment (DME)

28Total paid$12.37M

24GClaims222,402

24DCodes billed91

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Customized Equipment (DME) providers in Washington

Rank by total paid#5 of 43

Median peer was paid$2.19M

This provider vs. median5.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	13,033	$620K
2019	20,235	$948K
2020	28,775	$1.12M
2021	36,387	$2.04M
2022	41,799	$2.68M
2023	42,840	$2.64M
2024incomplete	39,333	$2.32M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	32%	40,662	37,987	$4.00M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	20%	32,732	31,093	$2.41M
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	9.4%	12,511	12,383	$1.17M
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	7.7%	10,950	10,514	$951K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	6.9%	6,761	6,552	$851K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	3.6%	4,839	4,788	$447K
97530	Therapeutic activities, direct patient contact, each 15 minutes	3.5%	5,540	2,179	$431K
99499		3.1%	15,058	14,826	$383K
99429		2.6%	13,558	13,360	$323K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.5%	3,740	3,576	$192K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	1.2%	1,590	1,541	$146K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	1.1%	3,331	1,222	$142K

79 more codes

87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.0%	4,070	$125K
99215	Doctor's office visit, returning patient (complex)	<1%	597	$90K
99177		<1%	23,405	$86K
D0120	Dental checkup, returning patient	<1%	3,712	$78K
99204	Doctor's office visit, new patient (more involved)	<1%	570	$77K
D9999	Unspecified adjunctive procedure, by report	<1%	3,587	$71K
90670		<1%	3,117	$44K
90686		<1%	2,738	$39K
99188		<1%	2,571	$27K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	1,293	$25K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	223	$19K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	189	$19K
90472	Immunization administration, each additional vaccine (list separately)	<1%	731	$17K
36416		<1%	4,078	$14K
96127		<1%	2,981	$13K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	32	$12K
D1206	Topical application of fluoride varnish	<1%	616	$11K
90633		<1%	754	$11K
99381		<1%	111	$9K
83655		<1%	859	$9K
90680		<1%	671	$9K
90671		<1%	617	$9K
90698		<1%	727	$8K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	230	$7K
E0570	Nebulizer, with compressor	<1%	61	$7K
99383		<1%	68	$7K
99382		<1%	70	$7K
90674		<1%	333	$6K
0071A		<1%	143	$6K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	840	$5K
96161		<1%	2,713	$5K
90836		<1%	103	$5K
0072A		<1%	95	$4K
95004	Percutaneous tests with allergenic extracts, immediate type reaction	<1%	31	$4K
90744		<1%	332	$3K
90833	Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on)	<1%	78	$3K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	49	$3K
0012A		<1%	83	$3K
90700		<1%	220	$3K
99205	Prolong outpt/office vis	<1%	12	$2K
90685		<1%	211	$2K
92522		<1%	37	$2K
90847	Family psychotherapy with the patient present, 50 minutes	<1%	28	$2K
90672		<1%	122	$1K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	111	$1K
0011A		<1%	100	$1K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	26	$1K
85018		<1%	570	$1K
90710		<1%	61	$1K
90707		<1%	80	$1K
92523		<1%	12	$1K
90697		<1%	68	$1K
54150		<1%	32	$1K
0002A		<1%	24	$960.00
90688		<1%	82	$926.09
90480		<1%	35	$836.00
87634		<1%	13	$739.86
88720		<1%	182	$739.05
97167		<1%	13	$704.73
90647		<1%	53	$588.28
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	74	$514.15
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	34	$426.88
90661		<1%	124	$402.38
91321		<1%	45	$295.61
90716		<1%	27	$283.03
90715		<1%	14	$275.66
90696		<1%	14	$275.66
90651		<1%	13	$255.97
90713		<1%	13	$250.18
90734		<1%	12	$236.28
90648		<1%	12	$216.59
81003		<1%	127	$200.69
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	28	$173.50
99173		<1%	141	$94.57
90660		<1%	13	$34.06
99072		<1%	4,320	$5.00
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	13	$1.08
99000		0%	498	$0.00
91301		0%	38	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialROOT, TAYLOR (ADMIN)